Reinforcement Learning, Explainable AI, Computational Psychiatry, Antidepressant Dose Optimization, Major Depressive Disorder, Treatment Personalization, Clinical Decision Support Share and Cite: de ...
This article contains 10 of what we believe to be the biggest stories we covered throughout the year on SD Times.
22h
Mabxience And Amneal Announces FDA Approval Of Denosumab Biosimilars Referencing Prolia® And XGEVA®
Mabxience And Amneal Announces FDA Approval Of Denosumab Biosimilars Referencing Prolia® And XGEVA®. mAbxience / Key word(s): Miscellaneous mAbxience and Amneal Announces FDA Approval of Denosumab ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback